COPD Flashcards

1
Q

what are pharmacological recommendations for cold per GOLD 2025

A

bronchodilators (laba, lama)
ics

if symptoms persist, then escalate LABA/LAMA OR LABA-ICS COMBO

INTRODUCTION OF NEW THERAPIES SUCH AS :
ENSIFENTRINE
DUPILUMAB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

WHAT ARE SURGICAL RECOMMENDATION FOR COPD PER GOLD 2025

A

LUNG VOLUME REDUCTION THERAPY

BRONCHOSCOPIC LUNG VOLUME REDUCTION (I.E ENDOBRONCHIAL COILS OR ENDOBRONCHIAL VALVES)

BULLECTOMY

LUNG TRANSPLANATAION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

WHAT ARE THERAPY RECOMMENDATIONS FOR COPD PER GOLD 2025

A

SMOKING CESSATION

VACCINATIONS

PULM REHAB

PHARM TX
BRONCHODILATORS
ICS
ENSIFENTRINE

LUNG VOLUME REDUCTION SURGERY

BRONCHOSCOPIC LUNG VOL REDUCTION

O2 THERAPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

WHAT ARE THE NUTRITION RECOMMENDATIONS FOR COPD PER GOLD 2025

A

CHOOSE COMPLEX CARBS

ADEQUEATE AMOUNT OF PROTIENS

OPT FOR HEALTHY FATS

ENSURE VITAMINS AND MINERALS (D, C, AND E AND POTASSIUM AND CALCIUM)

LIMIT PORCESSED FOODS

INCREASE HYDRATIONS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

WHAT TESTING RECOMMENDATIONS FOR COPD PER GOLD 2025

A

SPIROMETRY (PRE/POST BRONCHODILATOR)

LOW DOSE CT

CARDIOVASCULAR EVAL

PULM HYPERTENSION SCREENING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WHAT ARE THE DIFFERENT TYPES OF FREQUENCIES PER GOLD 2025 FOR COPD

A

EXACERBATION

SYMPTOM

MEDICATION USE

02 THERAPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

WHAT IS THE DIFFERENCE BETWEEN RESCUE OR RELIVER FOR COPD

A

USED INTERCHANGEABLY

THESE MEDICATIONS ARE TYPICALLY SHORT ACTING THAT WORK QUICKLY TO RELAX THE MUSCLES AROUND THE AIRWAYS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PRN MEDICATIONS PER GOLD 2025 FOR COPD

A

GROUP A - LOW SYMPTOMS/LOW EXACERBATION

GROUP B - HIGH SYMPTOMS/LOW EXACERBATION

GROUP E - HIGH EXACERBATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WHAT IS THE DIFFERENCE BETWEEN MAINTENANCE MEDS AND RESCUE/RELIEVER

A

MAINTENANCE - SCHEDULED TIME USE//DAILY AND REGULAR BASIS

RESCUE/RELIEVER - AS NEEDED/PRN//FOR IMMEDIATE SYMPTOMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

WHAT ARE EXAMPLES OF MAINTENANCE THERAPY

A

LABA

LAMA

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

WHAT DO THE ABBREVIATIONS MEAN

QD

BID

TID

QID

Q6H

A

QD - EVERY DAY

BID - 2X A DAY

TID - 3X A DAY

QID - 4X A DAY

Q6H - EVERY 6 HOURS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HOW DOES A ABG LOOK LIKE FOR COPD PT

A

PH - ACIDOIC

PACO2 - ELEVATED

PA02 - LOWER

HC03- ELEVATED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HOW DOES A PFT LOOK LIKE FOR COPD PT

A

FVC -DECREASED
FEV1 - DECREASED
FEV1/FVC RATIO - DECREASED
PEF - DECREASED
PEF 50% - DECREASED
PEF200-1200 -DECREASED

TIDAL VOL -NORMAL OR INCREASED
IPV - NORMAL OR DECREASED
ERV - NORMAL OR DECREASED
RV - NORMAL OR INACREASED

VC -DECREASED
IC - NORMAL OR DECREASED
FRC - INCREASED

TLC - NORMAL OR INCREASED
RV/TLC RATIO NORMAL OR INCREASED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

WHAT THERAPIES ARE USED TO ASSESS FOR IN ACUTE COPD EXACERBATION

A

SHORT ACTING BRONCHODILATORS (SABA FIRST LINE THERAPY)

SAMA - IPATROPIUM (ATROVENT)

COMBINATION THERAPY SABA + SAMA USED FOR BETTER SYMPTOM RELIEF AND INCREASED EFFECTIVENESS

SYSTEMIC STEROIDS (ORAL OR IV)

ABX - IF EXACERBATION IS LIKELY DUE TO A BACTERIAL INFECTION, PARTICULARLY IN PT WITH INCREASED SPUTUM PURULENCE OR WORSENG OF BASELINE SYMPTOMS

O2 THERAPY - GOAL SPO2 88-92%

EVALUATE FOR NIV
ASSESS FOR MECH VENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HOW DOES A CHEST XRAY LOOK LIKE FOR A COPD PT

A

COMMON FINDINGS

TRANSLUCENT (DARK) LUNG FIELDS

DEPRESSED OR FLATTENED DIAPHRAGM

LONG AND NARROW HEART (PULLED DOWNWARD BY DIAPHRAGM)

INCREASED RETROSTERNAL OR SPACE (LATERAL RADIOGRAPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WHAT LABORATORY TESTS ARE DONE FOR

A

HCT/HGB - POLYCYTHERMIA

ELECTROLYTES (EARLY AND LATE STAGES) - HYPOCHLOREMIA

HYPERNATREMIA (NA+)

SPUTUM EXAM - SPRETOCOCUS PNEUMONAIE
HEAMOPHILLUS INFLUENZAE
MORAXELLA CATARRHALIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

BREATH SOUNDS FOR COPD PT

A

WHEEZE OFTEN SEEN EXPIRATION

DECREASED BREATH SOUNDS - DUE TO HYPERINFLATION AND AIR TRAPPING

CRACKLES OR RALES IN PT WITH CONSISTENT PULM INFECTIONS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

WHAT IS A PINK PUFFER

A

A TERM USED TO DESCRIBE AN EMPHYSEMA OR COPD PT

PT HAVE BARREL CHEST DUE TO HYPERINFLATION

PUFFER REFERS TO THE FACT THESE PT ARE PURSED LIPPED

PT OFTEN REFERS TO THE FACT THE PT APPEARS WELL OXYGENATION (PINK SKIN TONE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

WHAT IS A BLUE BLOATER

A

A TERM USED TO DECSRIBE COPD PT WITH PREDOMINATELY CHRONIC BRONCHITIS

THESE PT TEND TO HAVE A CHRONIC COUGH, SPUTUM PORDUCTION AND CYANOSIS DUE TO SEVERE HYPOXEMIA

MAY DEVELOP RIGHT HEART FAILURE DUE TO LONG TERM PULM HYPERTENSION FROM HYPOXEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HOW DOES THE BP LOOK FOR COPD PT

A

PULSE PRESSURE CAN BE WIDENED WHICH MAY INDICATE CARDIOVASCULAR STRAIN

ELEVATED SYSTOLIC BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

WHAT ARE THE 2 TYPES OF EMPHYSEMA

A
  1. PANACINAR - ABNORMAL WEAKENING AND ENLARGEMENT OF ALL ALVEOLI DISTAL TO THE TERMINOLE BROCHIOLES
  2. CENTRIACINAR - INVOLVE THE RESP BRONCHIOLES IN THE PROXIMAL (CENTRAL) PORTION OF THE ACINUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MAJOR PATHOLOGIC OR STRUCTURAL CHANGES THAT ARE ASSOCIATED WITH CHRONIC BRONCHITIS

A
  1. CHRONIC INFLAMMATION AND THICKENING OF THE WALLS OF THE PERIPHERAL AIRWAYS
  2. EXCESSIVE MUCUS PRODUCTION AND ACCUMULATION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

WHAT IS CHRONIC BRONCHITIS

A

THE PRESENCE OF A COUGH AND SPUTUM PRODUCTION FOR 3 MONTHS IN EACH CONSECUTEIVE YEARS, REMAIN A CLINICALLY AND EPIDEMICOLOGICALLY USEFUL BUT IT IS PRESENT IN A MINORITY OF SUBJECTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

WHAT IS EMPHYSEMA

A

CHARACTERIZED BY A WEAKENING AND PERSISTENT ENLARGEMENT OF THE AIR SPACES DISTAL TO THE TERMINAL BRONCHIOLES AND BY THE DESTRUCTION OF THE ALVEOLI WALLS

25
WHAT HAPPENS TO THE DISTAL AIRWAYS IN EMPHYSEMA
WEAKENED HAVE MUCUS BUILD UP AND TEND TO COLLAPSE DURING EXPIRATION IN RESPONSE TO INCREASED INTRAPLEURAL PRESSURE
26
WHAT ARE THE RISK FACTORS FOR COPD
GENETIC FACTORS - ALPHA 1 ANTITRYPSIN DEF AGE AND GENDER - AS A PERSON AGES THE RISK INCREASES GREATER AMONG MEN LUNG GROWTH AND DEVELOPMENT - ISSUES DURING GESTATION AND CHILDHOOD HAS POTENTIAL TO IMPACT FOR COPD EXPOSURE TO PARTICLES: TOBACCO OCCUPTAIONAL EXPOSURE INDOOR/OUTDOOR AIR POLLUTION SOCIOECONIMIC STATUS - POVERTY IS A CLEARLY A RISK FACTOR FOR COPD BRONCHIAL/ASTHMA HYPERSENSITIVITY CHRONIC BRONCHITIS RESP INFECTIONS DYSPANAPSIS
27
WHAT IS DYSPANPSIS
HAS BEEN INTRODUCED TO REFER TO A MISMATCH BETWEEN THE NORMAL CALIBER OF TEH AIRWAYS AND THE LUNG PARENCHYCHEMA CAPACITY
28
WHAT TEST IS REQUIRED TO DX COPD
SPIROMETRY SHOWING A POST BRONCHIDILATOR FEV1/FVC OF LESS THAN 0.7
29
WHAT 3 MAIN SPIROMETRY TESTS ARE USED TO MEASURE THE SEVERITY OF AIRFLOW LIMITATION
FVC FEV1 FEV1/FVC RATIO
30
WHAT ARE THE QUESTIONANIRES USED TO ASSESS SYMPTOMS
mMRC BREATHLESSNESS SCALE COPD ASSESSMENT TEST
31
ATS DEFINITION OF PT WITH COPD
BRONCHITIS - BASED ON MAJOR CLINICAL MANIFESTATIONS ASSOCIATED WITH THE DISEASE EMPHYSEMA - IS BASED ON PATHOLOGY
32
PT WITH COPD WHAT IS NORMALLY PRESENT
BRONCHITIS AND EMPHYSEMA
33
ANATOMIC ALTERATIONS ASSOCIATED WITH BRONCHIATITS
CHRONIC INFLAMM ABD THICKENING OF THE WALL OF THE PERIPHERAL AIRWAYS EXCESSIVE MUCUS PRODUCTION AND ACCUMULATION PARTIAL OR TOTAL MUCUS PLUGGING SMOOTH MUSCLE CONSTRICTION OF THE BRONCHIAL AIRWAYS AIR TRAPPING AND HYPERINFLATION OF ALVEOLI
34
ANATOMIC ALTERATIONS ASSOCIATED WITH EMPHYSEMA
PERSISTENT ENLARGEMENT AND DESTRUCTION OF THE AIR SPACES DISTAL TO THE TERMINAL BRONCHIOLES DESTRUCTION OF ALVEOLAR CAP MEMBRANE WEAKENING OF THE DISTAL AIRWAYS, PRIMARILY THE RESP BRONCHIOLES AIR TRAPPING AND HYPERINFLATION
35
ETIOLOGY AND EPIDEMIOLOGY OF COPD
ESTIMATED BETWEEN 10-15 MILLION PEOPLE IN THE US STATES EITHER HAVE CHRONIC BRONCHITIS, EMPHYSEMA, OR A COMBINATION OF BOTH
36
RISK FACTORS ACCORDING TO GOLD
GENETIC PRE-DISPOSITION AGE AND GENDER CONDITIONS THAT AFFECTS NORMAL LUNG GROWTH EXPOSURE TO PARTICLES SOCIOECONIMIC STATUS ASTHMA/BRONCHIAL HYPERSENSITIVITY CHRONIC BRONCHITIS RESP INFECTIONS TB
37
KEY INDICATORS FOR CONDISERING COPD IN PT OVER 40
DYSPNEA CHRONIC COUGH CHRONIC SPUTUM HX OF EXPOSURE TO RISK FACTORS FAMILY HX OF COPD
38
GOLD RECOMMENDS COMBINING ALL THE ABOVE ASSESSMENTS TO DETERMINE COPD
SYMPTOM ASSESMENT AIR FLOW LIMITATION ASSESMENT RISK OF EXACERBATION ASSESSMENT
39
ADDITIONAL SCREENING TOOLS TO DX COPD
BODE INDEX CHEXT RADIOGRAPHS CT OF CHEST LUNG VOL AND DIFFUSING CAPACITY OXIMETRY AND ABG ALPHA 1 ANTITRYPSIN DEF SCREENING EXERCISE TESTING
40
INSPECTION SIGNS FOR COPD
PURSED LIP BREATHING COUGH MUCUS PRODUCTION
41
HOW DOES THE PALPATION OF THE CHEST IN EMPHYSEMA
DECREASED TACTILE FREMITUS DECREASED CHEST EXPANSION PMI SHIFTS TO THE EPIGASTRIC AREA
42
HOW DOES THE PALPATION OF THE CHEST IN CHRONIC BRONCHITIS
NORMAL
43
HOW IS THE PERCUSSION OF THE CHEST IN EMPHYSEMA
HYPERRESONANCE DECREASED DIAPHTAGMATIC EXCURSION
44
HOW IS THE PERCUSIION OF THE CHEST CHRINIC BRIONCHITIS
NORMAL
45
HOW IS THE AUSCULATAION OF THE CHEST FOR EMPHYSEMA
DIMINISHED BREATH SOUNDS PROLONGED EXPIRATION DIMINISHED HEART SOUNDS
46
HOW IS AUSCULTATION OF THE CHEST FOR CHRONIC BRONCHITIS
CRACKLES WHEEZE
47
WHAT IS A TELL TALE SIGN OF EMPHYSEMA
DECREASED DLCO
48
WHAT ARE 2 DANGEROUS ABG SITUATIONS FOR EMPYSEMA AND CHRONIC BRONCHITIS
1.ACUTE ALVEOLAR HYPERINFLATION SUPERIMPOSED ON A CHRONIC VENTILATIORY FAILURE 2. ACUTE VENTILATORY FAILURE (ACUTE HYPOVENTILATION)SUPERIMPOSED ON CHRONIC VENTILATORY FAILURE
49
HOW DOES HCT/HGB LOOK LIKE IN CHRONIC BRINCHITIS
POLYCYTHEMIA
50
HOW DOES ELECTROLYTES LOOK LIKE CHRONIC BRONCHITIS
HYPOCHLOREMEIA HYPERNATREMIA (NA+)
51
HOW IS SPUTUM IN EMPHYSEMA
NORMAL
52
HOW IS SPUTUM IN CHRONIC BRONCHITIS
STREPTOCOCCUS PNEUMONIAE HAEMOPHILUS INFUENZAE MORAXELLA CATARRHALIS
53
HOW DOES A BRONCHOGRAM LOOK LIKE FOR CHRONIC BRONCHITIS
SMALL SPIKELIKE PROTRUSIONS
54
HOW DOES CHEST RADIOGRAPH LOOK LIKE FOR CHRONIC BRONCHITIS
LUNGS MAY BE CLEAR IF ONLY IN LARGE BRONCHIOLES OCCASSIONALLY TRANSLUCENT DEPRESSED OR FLATTENED DIAPHRAGM
55
HOW DOES THE MANAGEMENT OF STABLE COPD LOOK LIKE
REDUCE EXPOSURE TO RISK FACTORS PHARMALOGIC TX NON PHARMOLOGIC TX
56
WHAT ARE THE COPD GRADES BASED ON SEVERITY OF AIRFLOW
GARDE 1 - MILD = FEV1 GREATER OR EQUAL TO 80% GRADE 2 - MODERATE = FEV1 50% LESS THAN 80% GRADE 3 - SEVERE = 30% LESS THAN 50% THAN PREDICTED GRADE 4 - VERY SEVERE = FEV 1 LESS THAN 30%
57
TX FOR GRADE 1 COPD
LABA + LAMA GROUP A - A BRONCHODILATOR GROUP B - LABA/LAMA
58
WHAT IS THE PHARMACOLOGIC MANAGEMENT OF COPD
GROUP A - SABA/LABA PRN GROUP B - LABA-LAMA MAINTENANCE SABA PRN GROUP E - LABA-LAMA (ASSESS FOR ICS) MAINTENANCE SABA PRN